Pharmaceutical

Enveda raises $130m to advance AI-driven plant based drug development

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.

Nov 23, 2024 - 06:00
Enveda raises $130m to advance AI-driven plant based drug development
The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.
Read the original article

Tags:

Previous Article

Europe’s TCR immunotherapy licensing deals surge 123% above US in 2024

Next Article

Amneal files again for FDA approval of first dihydroergotamine autoinjector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Why brain decoding is not mind reading — and why that matters

Opinion: Why brain decoding is not mind reading — and w...

Jun 8, 2023

Opinion: STAT+: An overlooked way to make participants in clinical trials look more like America

Opinion: STAT+: An overlooked way to make participants ...

May 27, 2023

STAT+: ‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug

STAT+: ‘Extraordinary’ survival data for lung cancer pa...

Jun 4, 2023